BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• McKesson to Showcase Clinical Expertise and Technology Solutions at ASHP Midyear Clinical Meeting 2017

  Visitors to McKesson Booth #1241 will have the opportunity to engage in one-on-one conversations with McKesson RxO advisors and get firsthand demonstrations of new technology solutions designed to address top pharmacy challenges.

  December 1, 2017

   · 

  7 min read
• Deals

  Quest Diagnostics Completes Acquisition of Cleveland HeartLab and Formalizes R&D Collaboration With Cleveland Clinic

  Quest will establish a national center of excellence focused on heart disease diagnostics within Cleveland HeartLab’s existing 25,000 square-foot clinical laboratory facility in Cleveland.

  December 1, 2017

   · 

  2 min read
• Biotech Bay

  Jaguar Health Announces Adjournment of Special Meeting of Stockholders Until Friday, December 15, 2017

  The Special Meeting has been adjourned to 8:00 a.m. Pacific Standard Time/11:00 a.m. Eastern Standard Time on Friday, December 15, 2017.

  December 1, 2017

   · 

  5 min read
• Business

  Aerie Pharmaceuticals Announces Appointment of Paul Bae as Vice President of Human Resources

  Mr. Bae will be responsible for leading the strategic human resources effort to recruit, develop and retain employees in the U.S., with an initial focus on further building Aerie’s commercial team.

  December 1, 2017

   · 

  5 min read
• 

  Drug Development

  Active Biotech’s Laquinimod Fails to Meet Primary Endpoint in Phase II Trial

  The primary endpoint of brain atrophy as defined by PBVC from baseline to week 48, was not met after daily oral doses with 0.6 mg laquinimod.

  December 1, 2017

   · 

  2 min read
• Business

  Bayer and the Broad Institute of MIT and Harvard Expand Partnership to Advance Drug Discovery Research for Novel Cancer Treatments

  Bayer and the Broad Institute of MIT and Harvard announced today that they have extended their multi-disciplinary research partnership by an additional five years, to develop and advance novel cancer treatments.

  December 1, 2017

   · 

  5 min read
• Biotech Beach

  Impact Biomedicines Closes First Tranche of Oberland Capital Financing Following FDA Meeting

  Impact Biomedicines announced that it has achieved the first milestone in the Company’s previously disclosed $90 million financing with Oberland Capital, triggering the closing on the first tranche of $20 million.

  December 1, 2017

   · 

  4 min read
• Pharm Country

  Tauriga Sciences Announces Board Approval for Up to $150,000 Share Buy-Back Program Effective Immediately

  The Company expects the purchases to be made from time to time in the open market or in unsolicited privately negotiated transactions, and that such purchases are expected to be funded from available cash on hand under Florida law.

  December 1, 2017

   · 

  3 min read
• Business

  Lonza, Akouos and MEE Announce Strategic Gene Therapy License Agreements on Hearing and Balance Disorders

  The agreement with Akouos is designed to accelerate AAV gene therapy for hearing and balance disorder.

  December 1, 2017

   · 

  3 min read
• NHS Rationing Reports are Red Flag for Dementia Treatment

  Alzheimer’s Research UK, the UK’s leading dementia research charity, is calling on the government to protect dementia treatments as the NHS copes with future budget concerns.

  December 1, 2017

   · 

  1 min read